Endometrial Advancement After Rec or u-HCG Triggering

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to investigate any potential advantages of replacing human chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for final oocyte maturation with regard to Ovarian hyperstimulation syndrome (OHSS)pathophysiology, endometrium receptivity and embryo quality and clinical pregnancy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitair Ziekenhuis Brussel
• Collaborator: Merck Serono International SA
• Treatments: Chorionic Gonadotropin

Criteria

Inclusion Criteria:

• Less than 36 years old

• Male or tubal infertility

• FSH<12 on day 3

Exclusion Criteria:

• Endometriosis stage 3 & 4